Eye Infections
15
1
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.7%
1 terminated out of 15 trials
88.9%
+2.4% vs benchmark
53%
8 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada
Immunotherapy in Eyelid Viral Papilloma
Total Infectome Characterization of Eye Infections
Optimizing Preoperative Disinfection of Eyes
The EXPLORE Study - The Use of Binocular OCT Imaging for the Assessment of Ocular Disease
Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples
Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection
Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora
The Influence of Hospital Environment on Eyes Infections in Medical Staff
A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte
Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers
Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery
Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers
Endophthalmitis Vitrectomy Study (EVS)
Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations